EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single‐cell analysis of Crohn's disease: Unveiling heterogeneity and evaluating ustekinumab outcomes

Zheng-Yang Li, Yong-Hong Sun, Qian-Hua, Hai-Yan Wang, Ya-Jie Wang, Miao-Jiang iD

The Journal of Gene Medicine · 2024

DOI: 10.1002/jgm.3715 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2024. Verfasst von Zheng-Yang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Jinshan Hospital of Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Crohn Disease, Ustekinumab, Single-Cell Analysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Commission of Jinshan District, Shanghai, China, Youth Research Fundation of Jinshan Hospital of Fudan University, Reserve discipline construction of Jinshan Hospital Affiliated to Fudan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The present study aimed to dissect the cellular complexity of Crohn's disease (CD) using single‐cell RNA sequencing, focusing on identifying key cell populations and their transcriptional profiles in inflamed tissue.

Methods

We applied scRNA‐sequencing to compare the cellular composition of CD patients with healthy controls, utilizing Seurat for clustering and annotation. Differential gene expression analysis and protein–protein interaction networks were constructed to identify crucial genes and pathways.

Results

Our study identified eight distinct cell types in CD, highlighting crucial fibroblast and T cell interactions. The analysis revealed key cellular communications and identified significant genes and pathways involved in the disease's pathology. The role of fibroblasts was underscored by elevated expression in diseased samples, offering insights into disease mechanisms and potential therapeutic targets, including responses to ustekinumab treatment, thus enriching our understanding of CD at a molecular level.

Conclusions

Our findings highlight the complex cellular and molecular interplay in CD, suggesting new biomarkers and therapeutic targets, offering insights into disease mechanisms and treatment implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseUstekinumabSingle-Cell AnalysisHumansGene Expression ProfilingProtein Interaction MapsFibroblastsBiomarkersFemaleTranscriptomeAdultMaleT-LymphocytesTreatment OutcomeSequence Analysis, RNAGene Regulatory Networks

Stichwörter der Autor:innen

Crohn's diseasecellular heterogeneityfibroblastssingle‐cell RNA sequencingustekinumab treatment

Substanzen

UstekinumabBiomarkers

Autor:innen und Institutionen

  • Department of Gastroenterology, Jinshan Hospital of Fudan University, Shanghai, China.
  • Department of Gastroenterology, Dalian Friendship Hospital, Dalian, Liaoning, China.

ORCID-Profile: Miao-Jiang

Förderung

  • Health Commission of Jinshan District, Shanghai, China
  • Youth Research Fundation of Jinshan Hospital of Fudan University
  • Reserve discipline construction of Jinshan Hospital Affiliated to Fudan University

Zitieren

APA

Li, Z. Y., Sun, Y. H., Qian-Hua, Wang, H. Y., Wang, Y. J., & Miao-Jiang (2024). Single‐cell analysis of Crohn's disease: Unveiling heterogeneity and evaluating ustekinumab outcomes. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3715

Vancouver

Li ZY, Sun YH, Qian-Hua, Wang HY, Wang YJ, Miao-Jiang. Single‐cell analysis of Crohn's disease: Unveiling heterogeneity and evaluating ustekinumab outcomes. The Journal of Gene Medicine. 2024. doi:10.1002/jgm.3715

BibTeX
@article{Li2024,
  author = {Li, Zheng-Yang and Sun, Yong-Hong and Qian-Hua and Wang, Hai-Yan and Wang, Ya-Jie and Miao-Jiang},
  title = {Single‐cell analysis of Crohn's disease: Unveiling heterogeneity and evaluating ustekinumab outcomes},
  journal = {The Journal of Gene Medicine},
  year = {2024},
  doi = {10.1002/jgm.3715}
}
Kostenlos starten →